Liquorice, a popular candy, may play a role in preventing or treating some types of cancers, according to researchers at the University of Illinois Chicago. The research findings were published in the journal 'Pharmacological Research.'

Gnanasekar Munirathinam and his research team are looking into chemicals produced from the liquorice plant Glycyrrhiza glabra to see whether they may be utilised to slow or stop prostate cancer growth. Munirathinam is an associate professor in the College of Medicine Rockford's department of biomedical sciences. Dr. Munirathinam and student researchers conducted a comprehensive evaluation of the molecular insights of a liquorice-derived substance called glycyrrhizin for cancer prevention and treatment, which shows that more research could lead to particular medications for therapeutic usage.

"Based on what we've seen in the research and our own findings, it appears that glycyrrhizin and its derivative glycyrrhetinic acid have a lot of promise as anti-inflammatory and anti-cancer medicines," Munirathinam said. "More research into exactly how these could best be used to build medicines is needed," Munirathinam said, "but this appears to be a promising area of cancer research."

Is it necessary for everyone to go out and consume a bunch of liquorice? Probably not, because it has the potential to influence blood pressure, interact with certain drugs, and produce significant side effects, including death, if used in excess. Until more research shows how to effectively utilise the plant's virtues, a sweet treat like liquorice candy or tea may be a better option. "There have been very few human clinical trials," Munirathinam said.

Ketogenic diet plus triple drug can prevent pancreatic cancer?

Want to stay healthy, so follow these 15 essential measures

These 10 good habits are the best to stay healthy, definitely try